Clinical Trials Directory

Trials / Unknown

UnknownNCT04112797

Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom

Prospective Observational Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Roxall Medicina España S.A · Industry
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

It is a safety and tolerability study of Allergovac Himenopteros in patients sensitized to Apis mellifera, Polistes Dominula or Vespula spp. To get this aim all adverse reactions will be recorded through the study. In addition, it will be evaluated the treatment efficacy with the re-sting after a year of treatment.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAllergovac himenopteraTreatment with allergy vaccine againts Apis mellifera, Vespula spp or Polistes dominula

Timeline

Start date
2019-05-23
Primary completion
2023-11-01
Completion
2023-11-01
First posted
2019-10-02
Last updated
2022-03-17

Locations

8 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04112797. Inclusion in this directory is not an endorsement.

Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom (NCT04112797) · Clinical Trials Directory